Antisense APOC3 oligonucleotide lowers triglyceride and atherogenic lipoproteins Presented ByProf. Jean-Claude Tardif, University of Montréal, Canada TrialPhase 2, AKCEA-APOCIII-LRx study ConferenceESC 2020 5 November, 2020 12:54